D iabetes mellitus is a public health problem affecting countries regardless of their level of development, moreover, the disease has multiple medical, social, and economic repercussions. Although numerous studies on the prevalence of diabetes mellitus have been conducted in Latin America, they are not comparable because different criteria were used and the samples were not representative. In Latin America, the prevalence of diabetes has been estimated to be between 2 and 12%; in Mexico, it is between 2 and 3%. The morbidity due to diabetes is not known because records are often inadequate; nevertheless, some information is available on hospital discharges and outpatient charts. However, the morbidity records vary in quality and completeness, and the data obtained from them only reveal part of the problem.
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MORTALITY
For the past several years in Mexico, diabetes mellitus has been listed among the 10 leading causes of death. The mortality rate was 8/100,000 inhabitants in 1960 and 22.9/100,000 in 1982. However, there is a lack of uniformity in the certification of cause of death, and frequently deaths among diabetic subjects are categorized as due to cardiovascular complications without mention of diabetes on the certificate (1).
In 1983, the geographic distribution of mortality attributed to diabetes was studied. In addition to observing that the rates were not uniform throughout the country, the study showed that diabetes was among the 10 leading causes of death in all states. Diabetes was the leading cause of death in Mexico City and the leading or second cause in many states that border the United States. Between 1978 and 1983, the mortality attributed to diabetes mellitus in relation to age was examined ( Table 1) . As expected, the rates are much higher in those aged ^45 yr. There appears to be a trend of increasing rates over time among people aged ^45 yr, and as in other countries, the rates are highest in people aged ^65 yr. In the same study, the proportion of deaths was greater in women than men at all ages ( Table 2) .
In 1988, a national health interview survey was conducted to determine the prevalence of the principal diseases in Mexico. Table 3 shows the prevalence of diabetes mellitus, as determined by the home questionnaire, in samples of the general population. Higher prevalences of diabetes mellitus were found in Baja California, Coahuila, and Chihuahua, which border the U.S., than elsewhere.
DATA FROM MEXICAN INSTITUTE OF SOCIAL SECURITY (IMSS)
Since 1980, the IMSS has had an information system that can determine the number of consultations in the three levels of medical care in the IMSS health-care system. In 1980, there were 433,148 consultations for diabetes at the primary-care level; this number has increased progressively in subsequent years reaching 1,529,307 in 1985 (Fig. 1) . However, these figures include both first time consultations and follow-up visits for diabetes and probably reflect an increasing preva- (Fig. 2) . The number of consultations increased almost threefold, whereas the population covered by IMSS did not change. Thus, these data showed a real increase in the prevalence of diabetes and its complications. Furthermore, 1 of 17 diabetic subjects was attending a clinic in the highly specialized hospital units.
Since 1976, the causes of death in IMSS hospitals have been recorded. In that year there were 1419 deaths attributed to diabetes, whereas in 1984 there were 6070 (Fig. 3) . Thus, from 1976 to 1984, the number of deaths attributed to diabetes quadrupled. In 1984, diabetes was the leading cause of death in the population covered by the IMSS. This means that diabetes surpassed cirrhosis, intestinal infections, respiratory diseases, and myocardial infarction as a cause of death. 
FIG. 2. Consultations for diabetes mellitus in tertiary-care hospitals almost tripled but population covered by Mexican Institute of Social Security did not, indicating a real increase in diabetes and its complications.
In 1969, a program for the detection of diabetes mellitus was started in Mexico; 46,540 cases were found and this figure increased every year until it reached 3,064,457 in 1983. Because the IMSS serves -1 8 million people >25 yr of age, the annual incidence of newly detected diabetes is considerable (Fig. 4) . 
DIABETES AND PREGNANCY
Gestational diabetes occurs during pregnancy in women who are obese, and its incidence increases with age. Many women who develop carbohydrate intolerance in pregnancy develop diabetes after childbirth. Gestational diabetes is a serious problem because it influences perinatal mortality. The most frequently observed complications of gestational diabetes are preeclampsia, macrosomia, hydramnios, and congenital malformations. What is also striking is the direct relation between mortality and the weight of the pregnant women; the greater the obesity, the greater the prevalence of morbidity and mortality (2, 5) . In Mexico, women are generally referred to specialized centers when they are 25-30 wk pregnant (6) . In these centers, perinatal mortality rates in women with gestational diabetes were ~6 of 1000 live births (Table  4) . However, when care is initiated only when pregnancy is advanced the outcome is much worse (Table  5 ). These data (3,4) emphasize the importance of monitoring for diabetes during pregnancy in the primary-care setting (5, 6) . Many women with gestational diabetes in Mexico are subsequently found to have impaired glucose tolerance or non-insulin-dependent diabetes mellitus when tested in the postpartum period (Table 6 ). Among women with gestational diabetes, the prevalence of diabetes mellitus after delivery was lower in Monterrey and Mexico than in San Luis Potosi. Despite attempts to determine the prevalence of diabetes mellitus in Mexico, available data do not reflect the rates or impact of the disease in the general population; continued efforts to determine the impact of diabetes on health care are needed. Non-insulin-dependent diabetes, usually associated with obesity, is the predominant type of diabetes in the country. Some statistical data indicate that diabetes is probably more prevalent in the states that border the U.S. (e.g., Nuevo Leon, Sonora, Chihuahua, and Baja California). Efforts are being made to determine the predominant complications of diabetes. There are indications that the frequent complications include blindness and amputations due to peripheral vascular insufficiency. Because the birth rate is high in Mexico, gestational diabetes is common. Widespread screening for diabetes in pregnant women would potentially result in lower perinatal morbidity and mortality and reduce the cost of care for high- Studies are necessary to establish the prevalence of diabetes in Mexico and the distribution of morbidity and mortality by age-group, weight, and duration of the disease. Genetic factors that determine the association of obesity and diabetes should be investigated. It is believed that the type of diet, in particular the type of carbohydrates and the amount of fiber, can influence the onset of diabetes mellitus. Mexican immigrants to the U.S. have a high prevalence of diabetes and this may be related to the process of adapting to another culture. Future studies in Mexico should initially focus on 7) prevalence, 2) knowledge of the risk factors, 3) studies on the demand of health services and cost-benefit analysis of medical care, and 4) frequency of both insulin-dependent and non-insulin-dependent diabetes.
